Quest Diagnostics Non-GAAP EPS of $2.50 beats by $0.13, revenue of $2.89B beats by $60M (DGX:NYSE)
Summary
Quest Diagnostics (DGX) Q1 earnings: EPS and revenue beat, FY26 guidance raised.
Description
Quest Diagnostics (DGX) Q1 earnings: EPS and revenue beat, FY26 guidance raised.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source